Clinical Report: Hepatitis E Beyond the Liver

Overview

Hepatitis E virus (HEV) presents diagnostic challenges due to its extrahepatic manifestations, which are often overlooked in clinical practice. Increased awareness of HEV's systemic nature is essential for timely diagnosis and management, particularly in at-risk populations.

Background

Hepatitis E is traditionally viewed as a liver disease, yet it can manifest in various extrahepatic forms, complicating diagnosis. In Europe, zoonotic HEV is prevalent, and its atypical presentations can lead to missed or delayed diagnoses, particularly in immunocompromised patients. Understanding the broader implications of HEV infection is crucial for effective clinical management.

Data Highlights

No numerical data available in the source material.

Key Findings

• HEV can cause neurological, renal, hematological, gastrointestinal, cardiovascular, endocrine, and muscular manifestations.
• Testing for HEV should be considered in patients with unexplained neurological symptoms, chronic liver disease, or persistent liver enzyme abnormalities.
• HEV is detected three times more often in men than in women, with the highest risk in men over 60 who consume meat.
• Diagnostic challenges include the limitations of serological assays and the short viremia period in zoonotic HEV infections.
• HEV IgG and IgM may develop simultaneously, complicating early diagnosis.
• False-negative results may occur in patients with primary immunodeficiency, while false positives can arise in autoimmune conditions.

Clinical Implications

Clinicians should maintain a low threshold for considering HEV in patients with atypical presentations, particularly those with neurological or renal symptoms. Enhanced diagnostic protocols that include HEV RNA testing are recommended, especially for immunocompromised patients.

Conclusion

Recognizing the systemic nature of HEV is vital for improving diagnostic accuracy and patient outcomes. A comprehensive approach to testing and awareness of extrahepatic manifestations can lead to better management of HEV infections.

Related Resources & Content

1. EASL Clinical Practice Guidelines on hepatitis E virus infection, EASL, 2018 -- EASL Clinical Practice Guidelines
2. WHO, Hepatitis E, 2023 -- WHO Fact Sheet
3. GOV.UK, Executive summary: hepatitis E virus transmission by blood transfusion, 2025 -- Review of current screening effectiveness
4. The pathologist, From Farm to Clinic: Tracking Hepatitis E, 2026 -- Tracking Hepatitis E
5. Infection — The Underreported Transmission of Hepatitis E in India: From Epidemiological Perspectives to Public Health Interventions - A Detailed Review
6. The Journal of Infectious Diseases — Hepatitis E Virus Infection in Patients With Chronic Liver Diseases: A Latin American Multicenter Study
7. Journal of Gastroenterology — Characterization of Hepatitis E Virus Antigens and the Immunogenicity and Effectiveness of Vaccination
8. EASL Clinical Practice Guidelines on hepatitis E virus infection
9. Hepatitis E
10. Executive summary: hepatitis E virus transmission by blood transfusion - review of current screening effectiveness - GOV.UK
11. Prevalence of Hepatitis A and E viruses in ready-to-eat foods: A meta-analysis - ScienceDirect
12. Biosecurity measures reducing Salmonella spp. and hepatitis E virus prevalence in pig farms-a systematic review and meta-analysis - PubMed
13. Beyond the liver: the broadened tissue tropism of hepatitis E virus - ScienceDirect
14. When hepatitis E viruses attack nerve cells | ScienceDaily
15. Treatment for chronic hepatitis E virus infection: A systematic review and meta‐analysis - PMC
16. Global vaccination against hepatitis E virus: position paper from the European Society of Clinical Microbiology and Infectious Diseases Viral Hepatitis Study Group - ScienceDirect
17. Hepatitis E vaccines